StockData
Lisata Therapeutics, Inc. logo

Lisata Therapeutics, Inc. (LSTA) shareholders

LSTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.04−0.05 (-4.59%)

Close on Nov 17, 2026Market cap $9.37MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
12.1%
1M of 9M shares
Institutional holders
31
3 new, 5 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Branham Justin Earl462,1495.10%13G (passive)Aug 21, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of LSTAValueChange% of portfolio
Vanguard Capital Management LLC278,8373.09%$948.05K+7,0220.00%
Yakira Capital Management, Inc.138,5611.54%$471.11KNew0.13%
Css LLC/Il110,4221.23%$375.44K+48,5240.01%
Deltec Asset Management LLC83,1970.92%$282.87K−6,8030.04%
Rangeley Capital, LLC81,0000.90%$275.40K+6,0000.25%
Geode Capital Management, LLC72,6320.81%$247.00K+1,7450.00%
Virtu Financial LLC58,7820.65%$200.00K+16,5690.01%
BlackRock, Inc.54,8570.61%$186.51K–0.00%
Vanguard Fiduciary Trust Co48,9640.54%$166.48K+14,0470.00%
Gts Securities LLC30,2000.34%$102.68K−1,1960.00%
State Street Corp25,3480.28%$86.18K–0.00%
Jane Street Group, LLC18,7410.21%$63.72KNew0.00%
Citadel Advisors LLC15,5410.17%$52.84K−7,1250.00%
Northern Trust Corp15,5340.17%$52.82K+5,2660.00%
JBF Capital, Inc.14,3470.16%$48.78K+1,1130.01%
Cerity Partners LLC12,1830.14%$41.42K–0.00%
Bank Of America Corp /De/10,3530.11%$35.20K–0.00%
HighTower Advisors, LLC10,0420.11%$34.14K–0.00%
International Assets Investment Management, LLC5,0000.06%$16.80K–0.00%
Founders Capital Management1,6670.02%$5.67K–0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026311M12.1%3 / 95 / 50M0M
Q1 2026331M11.6%13 / 53 / 41M0M
Q4 2025251M7.9%6 / 76 / 20M0M
Q3 2025211M8.2%3 / 55 / 20M0M
Q2 2025201M8.7%2 / 63 / 40M0M
Q1 2025221M8.7%3 / 65 / 20M0M
Q4 2024211M8.7%2 / 44 / 10M0M
Q3 2024201M8.5%2 / 74 / 30M0M
Q2 2024221M8.3%2 / 73 / 10M0M
Q1 2024211M8.3%1 / 75 / 20M0M
Q4 2023221M8.3%2 / 75 / 10M0M
Q3 2023211M7.6%3 / 82 / 40M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

10 funds held LSTA in Q2 2026, 81% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of LSTAValue% of fundAs of
Vanguard Total Stock Market Index Fund191,3712.12%$650.66K0.00%Jun 30, 2026
Vanguard Extended Market Index Fund80,4440.89%$273.51K0.00%Jun 30, 2026
Fidelity Extended Market Index Fund39,0030.43%$126.76K0.00%May 31, 2026
Fidelity Series Total Market Index Fund10,3730.12%$33.71K0.00%May 31, 2026
Vanguard Balanced Index Fund7,0220.08%$23.87K0.00%Jun 30, 2026
Fidelity Total Market Index Fund4,3790.05%$14.23K0.00%May 31, 2026
U.S. Social Core Equity 2 Portfolio2,1850.02%$2.16K0.00%Jul 31, 2026
Fidelity Nasdaq Composite Index Fund2,0100.02%$6.53K0.00%May 31, 2026
Dimensional US Sustainability Core 1 ETF1000.00%$990.00%Jul 31, 2026
Dimensional US Core Equity 1 ETF80.00%$80.00%Jul 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
David J. MazzoPresident & CEO, Director352,9863.92%Jan 13, 2026
Joshua Lehrer-GraiwerPresident & COO27,8080.31%Sep 28, 2026
Kristen K. BuckEVP, R&D and CMO95,6091.06%Jan 13, 2026
Tariq ImamSVP, Bus Dev, General Counsel36,5910.41%Jan 13, 2026
James NiscoSVP, Fin/Treas, Chief Actg Off32,3110.36%Jan 13, 2026
Jeffrey S. FarrowDirector0–Oct 15, 2026
Ted W. LoveDirector19,2600.21%Sep 28, 2026
Mohammad AzabDirector104,9251.16%Jan 13, 2026
Gregory B. BrownDirector95,6591.06%Jan 13, 2026
Cynthia Louise FlowersDirector95,4461.06%Jan 13, 2026
Steven M. KloskDirector95,8151.06%Jan 13, 2026
Heidi HensonDirector85,7250.95%Jan 13, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
James Nisco
SVP, Fin/Treas, Chief Actg Off
Jan 9, 2026Tax withholding−781$1.97$1.54K32,311
James Nisco
SVP, Fin/Treas, Chief Actg Off
Jan 9, 2026Award+15,000––38,491
James Nisco
SVP, Fin/Treas, Chief Actg Off
Jan 9, 2026Tax withholding−2,131$1.97$4.20K36,360
James Nisco
SVP, Fin/Treas, Chief Actg Off
Jan 9, 2026Tax withholding−2,131$1.97$4.20K34,229
James Nisco
SVP, Fin/Treas, Chief Actg Off
Jan 9, 2026Tax withholding−1,137$1.97$2.24K33,092
Tariq Imam
SVP, Bus Dev, General Counsel
Jan 9, 2026Tax withholding−747$1.97$1.47K36,591
Tariq Imam
SVP, Bus Dev, General Counsel
Jan 9, 2026Award+15,000––39,579
Tariq Imam
SVP, Bus Dev, General Counsel
Jan 9, 2026Tax withholding−1,401$1.97$2.76K38,178
Tariq Imam
SVP, Bus Dev, General Counsel
Jan 9, 2026Tax withholding−840$1.97$1.65K37,338
Tariq Imam
SVP, Bus Dev, General Counsel
Jan 9, 2026Tax withholding−513$1.97$1.01K36,078
Kristen K. Buck
EVP, R&D and CMO
Jan 9, 2026Tax withholding−3,221$1.97$6.35K95,609
Kristen K. Buck
EVP, R&D and CMO
Jan 9, 2026Tax withholding−2,982$1.97$5.87K98,830
Kristen K. Buck
EVP, R&D and CMO
Jan 9, 2026Tax withholding−2,147$1.97$4.23K93,462
Kristen K. Buck
EVP, R&D and CMO
Jan 9, 2026Award+25,000––104,794
Kristen K. Buck
EVP, R&D and CMO
Jan 9, 2026Tax withholding−2,982$1.97$5.87K101,812
Cynthia Louise Flowers
Director
Jan 9, 2026Award+30,456––95,446
Heidi Henson
Director
Jan 9, 2026Award+30,456––85,725
Mohammad Azab
Director
Jan 9, 2026Award+30,456––104,925
David J. Mazzo
President & CEO, Director
Jan 9, 2026Award+81,000––352,986
David J. Mazzo
President & CEO, Director
Jan 9, 2026Tax withholding−10,503$1.97$20.69K342,483
David J. Mazzo
President & CEO, Director
Jan 9, 2026Tax withholding−10,515$1.97$20.71K331,968
David J. Mazzo
President & CEO, Director
Jan 9, 2026Tax withholding−7,854$1.97$15.47K311,890
David J. Mazzo
President & CEO, Director
Jan 9, 2026Tax withholding−12,224$1.97$24.08K319,744
Gregory B. Brown
Director
Jan 9, 2026Award+30,456––95,659
Steven M. Klosk
Director
Jan 9, 2026Award+30,456––95,815
James Nisco
SVP, Fin/Treas, Chief Actg Off
Jan 10, 2025Tax withholding−416$3.73$1.55K23,491
David J. Mazzo
President & CEO, Director
Jan 10, 2025Tax withholding−3,106$3.73$11.59K264,690
Kristen K. Buck
EVP, R&D and CMO
Jan 10, 2025Tax withholding−456$3.73$1.70K79,794
Mohammad Azab
Director
Jan 9, 2025Award+15,789––74,469
James Nisco
SVP, Fin/Treas, Chief Actg Off
Jan 9, 2025Tax withholding−1,137$3.80$4.32K24,688
James Nisco
SVP, Fin/Treas, Chief Actg Off
Jan 9, 2025Tax withholding−781$3.80$2.97K23,907
James Nisco
SVP, Fin/Treas, Chief Actg Off
Jan 9, 2025Tax withholding−2,131$3.80$8.10K25,825
James Nisco
SVP, Fin/Treas, Chief Actg Off
Jan 9, 2025Award+15,000––27,956
Gregory B. Brown
Director
Jan 9, 2025Award+15,789––65,203
Steven M. Klosk
Director
Jan 9, 2025Award+15,789––65,359
Heidi Henson
Director
Jan 9, 2025Award+15,789––55,269
Cynthia Louise Flowers
Director
Jan 9, 2025Award+15,789––64,990
David J. Mazzo
President & CEO, Director
Jan 9, 2025Tax withholding−9,414$3.80$35.77K285,738
David J. Mazzo
President & CEO, Director
Jan 9, 2025Tax withholding−10,925$3.80$41.52K274,813
David J. Mazzo
President & CEO, Director
Jan 9, 2025Tax withholding−7,017$3.80$26.66K267,796
David J. Mazzo
President & CEO, Director
Jan 9, 2025Award+81,000––295,152
Kristen K. Buck
EVP, R&D and CMO
Jan 9, 2025Tax withholding−2,863$3.80$10.88K82,158
Kristen K. Buck
EVP, R&D and CMO
Jan 9, 2025Tax withholding−1,908$3.80$7.25K80,250
Kristen K. Buck
EVP, R&D and CMO
Jan 9, 2025Award+25,000––87,672
Kristen K. Buck
EVP, R&D and CMO
Jan 9, 2025Tax withholding−2,651$3.80$10.07K85,021
David J. Mazzo
President & CEO, Director
Oct 1, 2024Tax withholding−26,964$2.93$79.00K211,834
David J. Mazzo
President & CEO, Director
Oct 1, 2024Award+58,000$2.93$169.94K238,798
James Nisco
SVP, Fin/Treas, Chief Actg Off
Oct 1, 2024Award+3,300$2.93$9.67K14,657
James Nisco
SVP, Fin/Treas, Chief Actg Off
Oct 1, 2024Tax withholding−1,701$2.93$4.98K12,956
Kristen K. Buck
EVP, R&D and CMO
Oct 1, 2024Award+15,000$2.93$43.95K69,035
Kristen K. Buck
EVP, R&D and CMO
Oct 1, 2024Tax withholding−6,363$2.93$18.64K62,672
David J. Mazzo
Chief Executive Officer, Director
Jan 11, 2024Tax withholding−1,026$2.99$3.07K174,766
Kristen K. Buck
EVP, R&D and CMO
Jan 10, 2024Tax withholding−512$3.00$1.54K54,035
David J. Mazzo
Chief Executive Officer, Director
Jan 10, 2024Tax withholding−3,470$3.00$10.41K175,792
Mohammad Azab
Director
Jan 9, 2024Award+19,480––58,680
Steven M. Klosk
Director
Jan 9, 2024Award+19,480––49,570
Gregory B. Brown
Director
Jan 9, 2024Award+19,480––49,414
Kristen K. Buck
EVP, R&D and CMO
Jan 9, 2024Tax withholding−2,147$3.08$6.61K54,547
Kristen K. Buck
EVP, R&D and CMO
Jan 9, 2024Award+27,000––59,915
Kristen K. Buck
EVP, R&D and CMO
Jan 9, 2024Tax withholding−3,221$3.08$9.92K56,694

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
0.43%
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
+18.6%
From 0M shares
Short volume, 20 days
46.5%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Lisata Therapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 18,139 shares on Aug 24, 2026 over the last 90 days.

See a number that looks wrong?